RARE
Ultragenyx Pharmaceutical Inc
Price:  
39.90 
USD
Volume:  
578,644.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RARE Intrinsic Value

-927.20 %
Upside

As of 2024-05-24, the Intrinsic Value of Ultragenyx Pharmaceutical Inc (RARE) is (330.06) USD. This RARE valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 39.90 USD, the upside of Ultragenyx Pharmaceutical Inc is -927.20%.

The range of the Intrinsic Value is (726.23) - (217.73) USD

Note: result may not be accurate due to the invalid valuation result of DCF model.

39.90 USD
Stock Price
(330.06) USD
Intrinsic Value
Intrinsic Value Details

RARE Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) (726.23) - (217.73) (330.06) -927.2%
DCF (Growth 10y) (291.87) - (931.00) (433.89) -1187.4%
DCF (EBITDA 5y) (150.58) - (195.54) (1,234.50) -123450.0%
DCF (EBITDA 10y) (218.71) - (292.71) (1,234.50) -123450.0%
Fair Value -36.89 - -36.89 -36.89 -192.45%
P/E (213.94) - (210.99) (239.21) -699.5%
EV/EBITDA (142.26) - (123.79) (131.24) -428.9%
EPV (78.83) - (103.91) (91.37) -329.0%
DDM - Stable (55.07) - (205.23) (130.15) -426.2%
DDM - Multi (85.95) - (261.37) (130.85) -427.9%

RARE Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 3,316.89
Beta 1.46
Outstanding shares (mil) 83.13
Enterprise Value (mil) 3,204.64
Market risk premium 4.60%
Cost of Equity 10.31%
Cost of Debt 5.00%
WACC 7.64%